Gene Details



T and homologs in 4 species are found in 704 GeneSets:


- Entrez   - Ensembl   - GeneNetwork   - STRING   - Comparative Toxicogenomics Database  

Select gene sets below using the check boxes, and then add them to a project using the pull down below. You can also create a project using the pull down. To view a set, click on the GeneSetID:GeneSet Description shown in green below.
GS165707: MP:0000428 abnormal craniofacial morphology
GS185131: GO:0044699 single-organism process
GS187248: GO:0072359 circulatory system development
GS202082: GO:0051254 positive regulation of RNA metabolic process
GS166501: MP:0003189 fused joints
GS180039: GO:0032504 multicellular organism reproduction
GS165814: MP:0001922 reduced male fertility
GS185261: GO:0051254 positive regulation of RNA metabolic process
GS198861: GO:0007167 enzyme linked receptor protein signaling pathway
GS163534: MP:0004653 absent caudal vertebrae
GS203018: GO:0045935 positive regulation of nucleobase-containing compound metabolic process
GS164506: MP:0001698 decreased embryo size
GS167779: MP:0002632 vestigial tail
GS179428: GO:0022414 reproductive process
GS135641: circadian photosensitivity 2 (Circp2, Published QTL Chr 17)
GS191083: GO:0000003 reproduction
GS167063: MP:0001929 abnormal gametogenesis
GS191669: GO:0001067 regulatory region nucleic acid binding
GS167156: MP:0000459 abnormal presacral vertebrae morphology
GS195583: GO:0019953 sexual reproduction
GS180671: GO:0044454 nuclear chromosome part
GS199273: GO:0043233 organelle lumen
GS166753: MP:0001935 decreased litter size
GS191019: GO:0034641 cellular nitrogen compound metabolic process
GS163537: MP:0004656 absent sacral vertebrae
GS187887: GO:0080090 regulation of primary metabolic process
GS165643: MP:0011088 partial neonatal lethality
GS136170: leishmaniasis resistance 7 (Lmr7, Published QTL Chr 17)
GS177505: GO:0035148 tube formation
GS190039: GO:0009566 fertilization
GS195460: GO:0060348 bone development
GS203054: GO:0048514 blood vessel morphogenesis
GS163579: MP:0000539 distended urinary bladder
GS189669: GO:2000112 regulation of cellular macromolecule biosynthetic process
GS206108: GO:2001141 regulation of RNA biosynthetic process
GS192017: GO:0006139 nucleobase-containing compound metabolic process
GS166225: MP:0009850 embryonic lethality between implantation and placentation
GS194417: GO:0000790 nuclear chromatin
GS177404: GO:0005737 cytoplasm
GS167042: MP:0003885 abnormal rostral-caudal body axis extension
GS177265: GO:0048731 system development
GS207925: GO:0034645 cellular macromolecule biosynthetic process
GS201251: GO:0044424 intracellular part
GS193238: GO:0031323 regulation of cellular metabolic process
GS201404: GO:0009952 anterior/posterior pattern specification
GS203908: GO:0016070 RNA metabolic process
GS181893: GO:0048522 positive regulation of cellular process
GS163552: MP:0001684 abnormal axial mesoderm
GS188142: GO:0048856 anatomical structure development
GS165194: MP:0001533 abnormal skeleton physiology
GS165228: MP:0005382 craniofacial phenotype
GS164333: MP:0000516 abnormal renal/urinary system morphology
GS187973: GO:0061053 somite development
GS192829: GO:0021915 neural tube development
GS170243: MP:0011085 complete postnatal lethality
GS163650: MP:0004179 transmission ratio distortion
GS209551: GO:0031981 nuclear lumen
GS164258: MP:0002084 abnormal developmental patterning
GS193414: GO:0044249 cellular biosynthetic process
GS169928: MP:0004173 abnormal intervertebral disk morphology
GS186892: GO:0001840 neural plate development
GS169735: MP:0004543 abnormal sperm physiology
GS163067: MP:0005034 abnormal anus morphology
GS199757: GO:0035239 tube morphogenesis
GS199937: GO:0030509 BMP signaling pathway
GS198051: GO:0048562 embryonic organ morphogenesis
GS178922: GO:0003700 sequence-specific DNA binding transcription factor activity
GS201125: GO:0009790 embryo development
GS190393: GO:0007338 single fertilization
GS135556: CD8 memory T cell subset 5 (Cd8mts5, Published QTL Chr 17)
GS164406: MP:0004609 vertebral fusion
GS188757: GO:0009887 organ morphogenesis
GS190817: GO:0048609 multicellular organismal reproductive process
GS193937: GO:0006366 transcription from RNA polymerase II promoter
GS163627: MP:0001930 abnormal meiosis
GS179767: GO:0000976 transcription regulatory region sequence-specific DNA binding
GS199620: GO:0060429 epithelium development
GS197892: GO:0043228 non-membrane-bounded organelle
GS169460: MP:0004713 split notochord
GS179769: GO:0000975 regulatory region DNA binding
GS204628: GO:0007178 transmembrane receptor protein serine/threonine kinase signaling pathway
GS166409: MP:0002114 abnormal axial skeleton morphology
GS189484: GO:0023052 signaling
GS208231: GO:1901213 regulation of transcription from RNA polymerase II promoter involved in heart development
GS195143: GO:0016055 Wnt receptor signaling pathway
GS136120: body length 9 (Lgth9, Published QTL Chr 17)
GS195643: GO:0003677 DNA binding
GS198572: GO:0010604 positive regulation of macromolecule metabolic process
GS204472: GO:1901228 positive regulation of transcription from RNA polymerase II promoter involved in heart development
GS207720: GO:0048609 multicellular organismal reproductive process
GS135861: femur breaking strength 4 (Fembrs4, Published QTL Chr 17)
GS184317: GO:0009790 embryo development
GS164082: MP:0004672 short ribs
GS209956: GO:0003002 regionalization
GS195340: GO:0045893 positive regulation of transcription, DNA-dependent
GS196808: GO:0032501 multicellular organismal process
GS196532: GO:0000975 regulatory region DNA binding
GS168408: MP:0000585 kinked tail
GS186744: GO:0043226 organelle
GS163462: MP:0005650 abnormal limb bud morphology
GS167070: MP:0001921 reduced fertility
GS169828: MP:0005386 behavior/neurological phenotype
GS181035: GO:0001704 formation of primary germ layer
GS182835: GO:0005622 intracellular
GS166438: MP:0002231 abnormal primitive streak morphology
GS204511: GO:0048729 tissue morphogenesis
GS201756: GO:0042692 muscle cell differentiation
GS202415: GO:0044710 single-organism metabolic process
GS206544: GO:2000112 regulation of cellular macromolecule biosynthetic process
GS135331: autoimmune susceptibility in C57BL/6J and BALB/c 3 (Asbb3, Published QTL Chr 17)
GS182703: GO:0051171 regulation of nitrogen compound metabolic process
GS210178: GO:0031328 positive regulation of cellular biosynthetic process
GS169832: MP:0005381 digestive/alimentary phenotype
GS206923: GO:0009566 fertilization
GS181972: GO:0001838 embryonic epithelial tube formation
GS204108: GO:0072358 cardiovascular system development
GS194133: GO:0005737 cytoplasm
GS198360: GO:0006357 regulation of transcription from RNA polymerase II promoter
GS203406: GO:0009653 anatomical structure morphogenesis
GS206282: GO:0003257 positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation
GS84301: ethanol conditioned taste aversion (Published QTL, Chr 17)
GS164068: MP:0008854 bleb
GS166533: MP:0004509 abnormal pelvic girdle bone morphology
GS186790: GO:0006725 cellular aromatic compound metabolic process
GS163042: MP:0000269 abnormal heart looping
GS165805: MP:0002861 abnormal tail bud morphology
GS189415: GO:0003256 regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation
GS121161: Arsenic interacting genes (MeSH:D001151) in CTD
GS164372: MP:0004668 absent vertebral body
GS194111: GO:0097159 organic cyclic compound binding
GS199501: GO:0051173 positive regulation of nitrogen compound metabolic process
GS136265: modifier of mammary tumor progression 2 (Mmtp2, Published QTL Chr 17)
GS166437: MP:0002230 abnormal primitive streak formation
GS184318: GO:0009792 embryo development ending in birth or egg hatching
GS206329: GO:0060255 regulation of macromolecule metabolic process
GS207210: GO:0035295 tube development
GS135250: adiposity 18 (Adip18, Published QTL Chr 17)
GS185545: GO:0044212 transcription regulatory region DNA binding
GS195199: GO:0005634 nucleus
GS193234: GO:0031328 positive regulation of cellular biosynthetic process
GS166118: MP:0002109 abnormal limb morphology
GS201126: GO:0009792 embryo development ending in birth or egg hatching
GS136482: plasmacytoma susceptibility 4 (Pcyts4, Published QTL Chr 17)
GS163803: MP:0003631 nervous system phenotype
GS136634: small effect CIA locus 8 (Secia8, Published QTL Chr 17)
GS166581: MP:0004599 abnormal vertebral arch morphology
GS189240: GO:2001141 regulation of RNA biosynthetic process
GS206281: GO:0003256 regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation
GS165361: MP:0004624 abnormal thoracic cage morphology
GS166615: MP:0003410 abnormal artery development
GS186893: GO:0001843 neural tube closure
GS193857: GO:0055007 cardiac muscle cell differentiation
GS164488: MP:0005225 abnormal vertebrae development
GS182820: GO:0060429 epithelium development
GS186178: GO:0045935 positive regulation of nucleobase-containing compound metabolic process
GS189751: GO:0050794 regulation of cellular process
GS166590: MP:0002873 normal phenotype
GS163052: MP:0000266 abnormal heart morphology
GS182325: GO:0051716 cellular response to stimulus
GS198765: GO:0001838 embryonic epithelial tube formation
GS202371: GO:0044212 transcription regulatory region DNA binding
GS194159: GO:0009799 specification of symmetry
GS187343: GO:0006351 transcription, DNA-dependent
GS127012: Raloxifene interacting genes (MeSH:D020849) in CTD
GS209951: GO:0042127 regulation of cell proliferation
GS168920: MP:0002674 abnormal sperm motility
GS169391: MP:0002066 abnormal motor capabilities/coordination/movement
GS184731: GO:0035326 enhancer binding
GS185492: GO:0050789 regulation of biological process
GS169178: MP:0004073 caudal body truncation
GS163813: MP:0004645 decreased vertebrae number
GS181473: GO:0005488 binding
GS184445: GO:0044428 nuclear part
GS136304: modifier of Yaa 1 (Myaa1, Published QTL Chr 17)
GS180036: GO:0032501 multicellular organismal process
GS192345: GO:0010628 positive regulation of gene expression
GS196930: GO:0065007 biological regulation
GS200312: GO:0019219 regulation of nucleobase-containing compound metabolic process
GS177859: GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GS191150: GO:0010557 positive regulation of macromolecule biosynthetic process
GS181034: GO:0001707 mesoderm formation
GS163484: MP:0004837 abnormal neural fold formation
GS165365: MP:0004620 cervical vertebral fusion
GS198004: GO:0007399 nervous system development
GS168687: MP:0000592 short tail
GS169389: MP:0002060 abnormal skin morphology
GS164264: MP:0002082 postnatal lethality
GS204746: GO:0080090 regulation of primary metabolic process
GS197825: GO:0001704 formation of primary germ layer
GS163601: MP:0002089 abnormal postnatal growth/weight/body size
GS201249: GO:0044428 nuclear part
GS197244: GO:0044237 cellular metabolic process
GS169889: MP:0009053 abnormal anal canal morphology
GS185438: GO:0001568 blood vessel development
GS193991: GO:0048731 system development
GS198456: GO:0019438 aromatic compound biosynthetic process
GS163546: MP:0001688 abnormal somite development
GS166157: MP:0011097 complete embryonic lethality between somite formation and embryo turning
GS170137: MP:0001712 abnormal placenta development
GS183891: GO:0002009 morphogenesis of an epithelium
GS209775: GO:0021915 neural tube development
GS167074: MP:0001925 male infertility
GS166272: MP:0000288 abnormal pericardium morphology
GS181667: GO:0019438 aromatic compound biosynthetic process
GS165489: MP:0001700 abnormal embryo turning
GS204107: GO:0072359 circulatory system development
GS165163: MP:0006205 embryonic lethality between implantation and somite formation
GS190900: GO:0043009 chordate embryonic development
GS164514: MP:0001690 failure of somite differentiation
GS194088: GO:0003676 nucleic acid binding
GS178243: GO:0001158 enhancer sequence-specific DNA binding
GS188511: GO:0010468 regulation of gene expression
GS193014: GO:0003002 regionalization
GS165527: MP:0005378 growth/size phenotype
GS163899: MP:0000495 abnormal colon morphology
GS180089: GO:0030903 notochord development
GS209199: GO:0007165 signal transduction
GS178589: GO:0045893 positive regulation of transcription, DNA-dependent
GS184447: GO:0044424 intracellular part
GS187162: GO:0014028 notochord formation
GS193236: GO:0031326 regulation of cellular biosynthetic process
GS194519: GO:0014706 striated muscle tissue development
GS207813: GO:0048332 mesoderm morphogenesis
GS209863: GO:0050896 response to stimulus
GS202417: GO:0007368 determination of left/right symmetry
GS193072: GO:0060562 epithelial tube morphogenesis
GS170051: MP:0011495 abnormal head shape
GS168369: MP:0011256 abnormal neural fold morphology
GS167503: MP:0003054 spina bifida
GS191021: GO:0034645 cellular macromolecule biosynthetic process
GS199499: GO:0051171 regulation of nitrogen compound metabolic process
GS188272: GO:0035051 cardiac cell differentiation
GS203335: GO:0048513 organ development
GS180916: GO:0016331 morphogenesis of embryonic epithelium
GS188684: GO:0070013 intracellular organelle lumen
GS197049: GO:0009948 anterior/posterior axis specification
GS207298: GO:0072175 epithelial tube formation
GS186740: GO:0043229 intracellular organelle
GS166712: MP:0002161 abnormal fertility/fecundity
GS200690: GO:0002009 morphogenesis of an epithelium
GS201848: GO:0048598 embryonic morphogenesis
GS135877: femur geometry 14 (Fmgty14, Published QTL Chr 17)
GS129164: progressive hearing loss 1 (Phl1 Published QTL Chr 17)
GS196540: GO:0043565 sequence-specific DNA binding
GS169477: MP:0006392 abnormal nucleus pulposus morphology
GS189794: GO:0000980 RNA polymerase II distal enhancer sequence-specific DNA binding
GS169017: MP:0002932 abnormal joint morphology
GS182475: GO:0043233 organelle lumen
GS193987: GO:0048738 cardiac muscle tissue development
GS196531: GO:0000977 RNA polymerase II regulatory region sequence-specific DNA binding
GS188506: GO:0010467 gene expression
GS208012: GO:0044464 cell part
GS210212: GO:0005575 cellular_component
GS195291: GO:0006355 regulation of transcription, DNA-dependent
GS201239: GO:0046483 heterocycle metabolic process
GS205369: GO:0010468 regulation of gene expression
GS188763: GO:0009888 tissue development
GS192073: GO:1901576 organic substance biosynthetic process
GS36670: Hippocampus Gene expression correlates of Morphine vertical activity counts minutes 165-180 in Males BXD
GS181262: GO:0048562 embryonic organ morphogenesis
GS188399: GO:0044238 primary metabolic process
GS188762: GO:0009889 regulation of biosynthetic process
GS206623: GO:0050794 regulation of cellular process
GS208060: GO:0010557 positive regulation of macromolecule biosynthetic process
GS193663: GO:0048570 notochord morphogenesis
GS169115: MP:0009929 meningomyelocele
GS184435: GO:0046483 heterocycle metabolic process
GS186395: GO:0000228 nuclear chromosome
GS187370: GO:0001071 nucleic acid binding transcription factor activity
GS203402: GO:0007498 mesoderm development
GS164261: MP:0002081 perinatal lethality
GS178827: GO:0019953 sexual reproduction
GS186214: GO:0048518 positive regulation of biological process
GS187545: GO:0060606 tube closure
GS201858: GO:0009855 determination of bilateral symmetry
GS194038: GO:1901362 organic cyclic compound biosynthetic process
GS165612: MP:0002128 abnormal blood circulation
GS204019: GO:0014020 primary neural tube formation
GS205623: GO:0009888 tissue development
GS204440: GO:0010002 cardioblast differentiation
GS168295: MP:0003698 abnormal male reproductive system physiology
GS166822: MP:0000461 decreased presacral vertebrae number
GS166194: MP:0009931 abnormal skin appearance
GS168088: MP:0011110 partial preweaning lethality
GS167525: MP:0000154 rib fusion
GS163050: MP:0000260 abnormal angiogenesis
GS129089: bronchial hyperresponsiveness 3 (Bhr3 Published QTL Chr 17)
GS194206: GO:0007341 penetration of zona pellucida
GS193012: GO:0003007 heart morphogenesis
GS207807: GO:0043009 chordate embryonic development
GS166711: MP:0002160 abnormal reproductive system morphology
GS177310: GO:1901360 organic cyclic compound metabolic process
GS168149: MP:0005508 abnormal skeleton morphology
GS164588: MP:0003051 curly tail
GS167020: MP:0003956 abnormal body size
GS165616: MP:0002127 abnormal cardiovascular system morphology
GS179357: GO:0001012 RNA polymerase II regulatory region DNA binding
GS210180: GO:0031326 regulation of cellular biosynthetic process
GS169833: MP:0005380 embryogenesis phenotype
GS182834: GO:0005623 cell
GS194991: GO:0001158 enhancer sequence-specific DNA binding
GS205622: GO:0009889 regulation of biosynthetic process
GS208657: GO:0008284 positive regulation of cell proliferation
GS191151: GO:0010556 regulation of macromolecule biosynthetic process
GS198056: GO:0048568 embryonic organ development
GS209282: GO:0010628 positive regulation of gene expression
GS121593: 2-amino-4-phosphonobutyric acid interacting genes (MeSH:C012729) in CTD
GS189460: GO:0060255 regulation of macromolecule metabolic process
GS183137: GO:0030509 BMP signaling pathway
GS169530: MP:0005390 skeleton phenotype
GS178448: GO:0005634 nucleus
GS84298: cocaine induced activation (Published QTL, Chr 17)
GS187768: GO:0007178 transmembrane receptor protein serine/threonine kinase signaling pathway
GS182474: GO:0043232 intracellular non-membrane-bounded organelle
GS199635: GO:0005622 intracellular
GS165075: MP:0005227 abnormal vertebral body development
GS184118: GO:0023019 signal transduction involved in regulation of gene expression
GS168012: MP:0010832 lethality during fetal growth through weaning
GS179768: GO:0000977 RNA polymerase II regulatory region sequence-specific DNA binding
GS168013: MP:0010831 partial lethality
GS185043: GO:0009855 determination of bilateral symmetry
GS197824: GO:0001707 mesoderm formation
GS167075: MP:0001924 infertility
GS208061: GO:0010556 regulation of macromolecule biosynthetic process
GS178537: GO:0006355 regulation of transcription, DNA-dependent
GS185937: GO:0005694 chromosome
GS189820: GO:0044702 single organism reproductive process
GS196943: GO:0008152 metabolic process
GS187146: GO:0044700 single organism signaling
GS204023: GO:0014028 notochord formation
GS202261: GO:0001568 blood vessel development
GS168379: MP:0002151 abnormal neural tube morphology/development
GS185740: GO:0048706 embryonic skeletal system development
GS199612: GO:0061371 determination of heart left/right asymmetry
GS167224: MP:0000141 abnormal vertebral body morphology
GS165244: MP:0010771 integument phenotype
GS196941: GO:0008150 biological_process
GS187610: GO:1901228 positive regulation of transcription from RNA polymerase II promoter involved in heart development
GS182069: GO:0007167 enzyme linked receptor protein signaling pathway
GS199634: GO:0005623 cell
GS165567: MP:0008271 abnormal bone ossification
GS164136: MP:0000001 mammalian phenotype
GS169461: MP:0004712 notochord degeneration
GS162909: MP:0008999 absent anus
GS164105: MP:0003047 abnormal thoracic vertebrae morphology
GS190893: GO:0030154 cell differentiation
GS197470: GO:0044454 nuclear chromosome part
GS187648: GO:0048729 tissue morphogenesis
GS186079: GO:0035282 segmentation
GS187045: GO:0016070 RNA metabolic process
GS201256: GO:0044422 organelle part
GS168151: MP:0001914 hemorrhage
GS205616: GO:0009887 organ morphogenesis
GS162897: MP:0003984 embryonic growth retardation
GS204007: GO:0044700 single organism signaling
GS209954: GO:0003007 heart morphogenesis
GS210182: GO:0031323 regulation of cellular metabolic process
GS187158: GO:0014020 primary neural tube formation
GS189416: GO:0003257 positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation
GS195060: GO:0051146 striated muscle cell differentiation
GS200744: GO:0000578 embryonic axis specification
GS207964: GO:0007509 mesoderm migration involved in gastrulation
GS165214: MP:0001711 abnormal placenta morphology
GS209411: GO:0048869 cellular developmental process
GS186211: GO:0048514 blood vessel morphogenesis
GS187578: GO:0010002 cardioblast differentiation
GS124911: PD 169316 interacting genes (MeSH:C408604) in CTD
GS187160: GO:0044707 single-multicellular organism process
GS177761: GO:0044271 cellular nitrogen compound biosynthetic process
GS168921: MP:0002675 asthenozoospermia
GS190682: GO:0007275 multicellular organismal development
GS169185: MP:0000755 hindlimb paralysis
GS166925: MP:0002825 abnormal notochord morphology
GS181783: GO:0010604 positive regulation of macromolecule metabolic process
GS169172: MP:0006386 absent somites
GS193059: GO:0044446 intracellular organelle part
GS167796: MP:0008770 decreased survivor rate
GS210181: GO:0031325 positive regulation of cellular metabolic process
GS167047: MP:0004573 absent limb buds
GS87065: Table S4: List of Saline-Treated HDAC5 KO vs. Saline-Treated WT Significantly Regulated Genes. [DRG] provisional
GS182074: GO:0000785 chromatin
GS209564: GO:0043231 intracellular membrane-bounded organelle
GS166427: MP:0004608 abnormal cervical axis morphology
GS191312: GO:1901213 regulation of transcription from RNA polymerase II promoter involved in heart development
GS135576: cystic fibrosis lung disease 3 (Cfld3, Published QTL Chr 17)
GS136800: total body bone mineral density 7 (Tbbmd7, Published QTL Chr 17)
GS202080: GO:0051252 regulation of RNA metabolic process
GS166579: MP:0005221 abnormal rostral-caudal axis patterning
GS170198: MP:0001614 abnormal blood vessel morphology
GS165160: MP:0006207 embryonic lethality during organogenesis
GS170107: MP:0003720 abnormal neural tube closure
GS204568: GO:0009893 positive regulation of metabolic process
GS163620: MP:0002086 abnormal extraembryonic tissue morphology
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
GS165427: MP:0000432 abnormal head morphology
GS192357: GO:0036342 post-anal tail morphogenesis
GS191057: GO:0007509 mesoderm migration involved in gastrulation
GS164968: MP:0001726 abnormal allantois morphology
GS136400: organ weight 9 (Org9, Published QTL Chr 17)
GS204021: GO:0044707 single-multicellular organism process
GS205047: GO:0006807 nitrogen compound metabolic process
GS180437: GO:0001570 vasculogenesis
GS184629: GO:0005515 protein binding
GS169603: MP:0001672 abnormal embryogenesis/ development
GS164482: MP:0001216 abnormal epidermal layer morphology
GS166404: MP:0002113 abnormal skeleton development
GS185735: GO:0048705 skeletal system morphogenesis
GS196811: GO:0032504 multicellular organism reproduction
GS202775: GO:0005694 chromosome
GS179211: GO:0007154 cell communication
GS205127: GO:0035051 cardiac cell differentiation
GS192265: GO:0007165 signal transduction
GS196124: GO:0001012 RNA polymerase II regulatory region DNA binding
GS180152: GO:0065007 biological regulation
GS177472: GO:0007341 penetration of zona pellucida
GS184601: GO:0009952 anterior/posterior pattern specification
GS166793: MP:0006279 abnormal limb development
GS165536: MP:0005371 limbs/digits/tail phenotype
GS186488: GO:0048513 organ development
GS165397: MP:0001265 decreased body size
GS178393: GO:0016055 Wnt receptor signaling pathway
GS191030: GO:0007507 heart development
GS164450: MP:0005191 head tilt
GS169095: MP:0004924 abnormal behavior
GS164624: MP:0004613 fusion of vertebral arches
GS166718: MP:0002169 no abnormal phenotype detected
GS201536: GO:0035326 enhancer binding
GS166160: MP:0011092 complete embryonic lethality
GS197821: GO:0001702 gastrulation with mouth forming second
GS196806: GO:0032502 developmental process
GS208664: GO:0008283 cell proliferation
GS181215: GO:0007399 nervous system development
GS203594: GO:0043226 organelle
GS164182: MP:0000489 abnormal large intestine morphology
GS205364: GO:0010467 gene expression
GS207498: GO:0001501 skeletal system development
GS166203: MP:0005169 abnormal male meiosis
GS164873: MP:0006281 abnormal tail development
GS209009: GO:1901576 organic substance biosynthetic process
GS170093: MP:0000259 abnormal vascular development
GS190949: GO:0009058 biosynthetic process
GS165537: MP:0005376 homeostasis/metabolism phenotype
GS190906: GO:0048332 mesoderm morphogenesis
GS164392: MP:0003050 abnormal sacral vertebrae morphology
GS166246: MP:0002759 abnormal caudal vertebrae morphology
GS182705: GO:0051173 positive regulation of nitrogen compound metabolic process
GS136378: obesity QTL 4 (Obq4, Published QTL Chr 17)
GS166655: MP:0005226 abnormal vertebral arch development
GS198866: GO:0000785 chromatin
GS203593: GO:0043227 membrane-bounded organelle
GS181102: GO:0043228 non-membrane-bounded organelle
GS201265: GO:0009891 positive regulation of biosynthetic process
GS207991: GO:0000003 reproduction
GS177308: GO:1901362 organic cyclic compound biosynthetic process
GS166405: MP:0002111 abnormal tail morphology
GS210000: GO:0044446 intracellular organelle part
GS135616: circulating hormone level QTL 8 (Chlq8, Published QTL Chr 17)
GS202316: GO:0050789 regulation of biological process
GS194087: GO:0003674 molecular_function
GS168750: MP:0002191 abnormal artery morphology
GS184461: GO:0009891 positive regulation of biosynthetic process
GS196196: GO:0022414 reproductive process
GS177356: GO:0003674 molecular_function
GS178885: GO:0003677 DNA binding
GS203590: GO:0043229 intracellular organelle
GS204831: GO:0061053 somite development
GS165161: MP:0006206 embryonic lethality between somite formation and embryo turning
GS180001: GO:0048646 anatomical structure formation involved in morphogenesis
GS206220: GO:0060395 SMAD protein signal transduction
GS177309: GO:1901363 heterocyclic compound binding
GS189356: GO:0060395 SMAD protein signal transduction
GS204410: GO:0060606 tube closure
GS136479: periosteal circumference 4 (Pcir4, Published QTL Chr 17)
GS201321: GO:0090009 primitive streak formation
GS188410: GO:0032774 RNA biosynthetic process
GS192471: GO:0048869 cellular developmental process
GS177754: GO:0001944 vasculature development
GS180166: GO:0008152 metabolic process
GS191727: GO:0008283 cell proliferation
GS192093: GO:0000981 sequence-specific DNA binding RNA polymerase II transcription factor activity
GS205619: GO:0009880 embryonic pattern specification
GS167005: MP:0004787 abnormal dorsal aorta morphology
GS203675: GO:0060379 cardiac muscle cell myoblast differentiation
GS185588: GO:0007369 gastrulation
GS136909: vertebral morphology and mechanical traits 14 (Vmmt14, Published QTL Chr 17)
GS202566: GO:0048705 skeletal system morphogenesis
GS203072: GO:0090304 nucleic acid metabolic process
GS198768: GO:0001839 neural plate morphogenesis
GS177382: GO:0097159 organic cyclic compound binding
GS206669: GO:0000980 RNA polymerase II distal enhancer sequence-specific DNA binding
GS186891: GO:0001841 neural tube formation
GS195678: GO:0003700 sequence-specific DNA binding transcription factor activity
GS201253: GO:0044427 chromosomal part
GS185659: GO:0090130 tissue migration
GS190605: GO:0001501 skeletal system development
GS194241: GO:0035148 tube formation
GS202572: GO:0048706 embryonic skeletal system development
GS177426: GO:0009799 specification of symmetry
GS208604: GO:0001067 regulatory region nucleic acid binding
GS128599: Ethanol Induced Ataxia Chr#17
GS164109: MP:0003048 abnormal cervical vertebrae morphology
GS169233: MP:0000138 absent vertebrae
GS163811: MP:0004643 abnormal vertebrae number
GS169179: MP:0000753 paralysis
GS164509: MP:0001695 abnormal gastrulation
GS205543: GO:0070013 intracellular organelle lumen
GS186824: GO:0060379 cardiac muscle cell myoblast differentiation
GS164390: MP:0005297 spina bifida occulta
GS168956: MP:0003491 abnormal voluntary movement
GS168892: MP:0000292 distended pericardium
GS169365: MP:0000923 abnormal roof plate morphology
GS164110: MP:0003049 abnormal lumbar vertebrae morphology
GS187751: GO:0019222 regulation of metabolic process
GS136804: tibia bone quality traits 6 (Tbqt6, Published QTL Chr 17)
GS169663: MP:0004703 abnormal vertebral column morphology
GS193237: GO:0031325 positive regulation of cellular metabolic process
GS195214: GO:0009987 cellular process
GS163934: MP:0001764 abnormal homeostasis
GS184452: GO:0044422 organelle part
GS204204: GO:0006351 transcription, DNA-dependent
GS180034: GO:0032502 developmental process
GS199124: GO:0051716 cellular response to stimulus
GS200648: GO:0044260 cellular macromolecule metabolic process
GS165525: MP:0010768 mortality/aging
GS203748: GO:0001840 neural plate development
GS170442: MP:0010866 abnormal prenatal body size
GS181975: GO:0001839 neural plate morphogenesis
GS194602: GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GS195683: GO:0003705 RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity
GS203747: GO:0001841 neural tube formation
GS169648: MP:0000932 absent notochord
GS197227: GO:0001570 vasculogenesis
GS136685: skull morphology 24 (Skull24, Published QTL Chr 17)
GS185259: GO:0051252 regulation of RNA metabolic process
GS203642: GO:0006725 cellular aromatic compound metabolic process
GS164770: MP:0009250 abnormal appendicular skeleton morphology
GS202909: GO:0035282 segmentation
GS168174: MP:0001919 abnormal reproductive system physiology
GS207923: GO:0034641 cellular nitrogen compound metabolic process
GS190314: GO:0035295 tube development
GS168567: MP:0011091 complete prenatal lethality
GS163531: MP:0004659 abnormal odontoid process morphology
GS198263: GO:0005488 binding
GS187249: GO:0072358 cardiovascular system development
GS194040: GO:1901360 organic cyclic compound metabolic process
GS193009: GO:0042127 regulation of cell proliferation
GS210016: GO:0060562 epithelial tube morphogenesis
GS86932: Table S3: CORTEX 17K MICROARRAY [DRG]
GS206355: GO:0023052 signaling
GS192918: GO:0050896 response to stimulus
GS84299: ethanol metabolism rate (Published QTL, Chr 17)
GS204040: GO:0009798 axis specification
GS206182: GO:0060537 muscle tissue development
GS190067: GO:0018130 heterocycle biosynthetic process
GS165524: MP:0010769 abnormal survival
GS207736: GO:0008595 anterior/posterior axis specification, embryo
GS169609: MP:0001674 abnormal triploblastic development
GS202820: GO:0001756 somitogenesis
GS129074: alloantigen response 1 (Alan1 Published QTL Chr 17)
GS205266: GO:0032774 RNA biosynthetic process
GS124312: sodium arsenite interacting genes (MeSH:C017947) in CTD
GS195977: GO:0007154 cell communication
GS169234: MP:0000137 abnormal vertebrae morphology
GS165243: MP:0010770 preweaning lethality
GS166535: MP:0010865 prenatal growth retardation
GS207935: GO:0007507 heart development
GS136549: proteinuria 2 (Ptnu2, Published QTL Chr 17)
GS179777: GO:0043565 sequence-specific DNA binding
GS185983: GO:0001756 somitogenesis
GS178703: GO:0060348 bone development
GS194267: GO:0043170 macromolecule metabolic process
GS210357: GO:0044249 cellular biosynthetic process
GS180452: GO:0044237 cellular metabolic process
GS164247: MP:0001680 abnormal mesoderm development
GS178702: GO:0060349 bone morphogenesis
GS206953: GO:0018130 heterocycle biosynthetic process
GS163724: MP:0000436 abnormal head movements
GS169149: MP:0003400 kinked neural tube
GS203057: GO:0048518 positive regulation of biological process
GS164860: MP:0004607 abnormal cervical atlas morphology
GS165798: MP:0005367 renal/urinary system phenotype
GS194499: GO:0044271 cellular nitrogen compound biosynthetic process
GS196530: GO:0000976 transcription regulatory region sequence-specific DNA binding
GS180164: GO:0008150 biological_process
GS177357: GO:0003676 nucleic acid binding
GS177531: GO:0043170 macromolecule metabolic process
GS207289: GO:0007338 single fertilization
GS167505: MP:0008762 embryonic lethality
GS205255: GO:0044238 primary metabolic process
GS169829: MP:0005385 cardiovascular system phenotype
GS196772: GO:0048646 anatomical structure formation involved in morphogenesis
GS177214: GO:0006366 transcription from RNA polymerase II promoter
GS182956: GO:0035239 tube morphogenesis
GS164235: MP:0003087 absent allantois
GS186562: GO:0009653 anatomical structure morphogenesis
GS207858: GO:0009059 macromolecule biosynthetic process
GS186558: GO:0007498 mesoderm development
GS136260: male hybrid sterility QTL 1 (Mhstq1, Published QTL Chr 17)
GS136372: obesity QTL 19 (Obq19, Published QTL Chr 17)
GS202418: GO:0007369 gastrulation
GS195459: GO:0060349 bone morphogenesis
GS164262: MP:0002080 prenatal lethality
GS164511: MP:0001697 abnormal embryo size
GS167307: MP:0002925 abnormal cardiovascular development
GS200918: GO:0023019 signal transduction involved in regulation of gene expression
GS163635: MP:0001933 abnormal litter size
GS177813: GO:0031974 membrane-enclosed lumen
GS184218: GO:0071704 organic substance metabolic process
GS185587: GO:0007368 determination of left/right symmetry
GS193610: GO:0007389 pattern specification process
GS192610: GO:0031981 nuclear lumen
GS166156: MP:0011096 complete embryonic lethality between implantation and somite formation
GS183514: GO:0019219 regulation of nucleobase-containing compound metabolic process
GS183848: GO:0044260 cellular macromolecule metabolic process
GS186757: GO:0034654 nucleobase-containing compound biosynthetic process
GS164257: MP:0002085 abnormal embryonic tissue morphology
GS165362: MP:0004623 thoracic vertebral fusion
GS166825: MP:0000462 abnormal digestive system morphology
GS169371: MP:0000929 open neural tube
GS167918: MP:0000955 abnormal spinal cord morphology
GS198685: GO:0048522 positive regulation of cellular process
GS163548: MP:0001689 incomplete somite formation
GS167813: MP:0000163 abnormal cartilage morphology
GS201949: GO:0044699 single-organism process
GS166951: MP:0001156 abnormal spermatogenesis
GS208954: GO:0006139 nucleobase-containing compound metabolic process
GS83971: cocaine induced activation 3 (Cocia3, Published QTL, Chr 17)
GS166697: MP:0001539 decreased caudal vertebrae number
GS209028: GO:0000981 sequence-specific DNA binding RNA polymerase II transcription factor activity
GS168549: MP:0000477 abnormal intestine morphology
GS190950: GO:0009059 macromolecule biosynthetic process
GS181568: GO:0006357 regulation of transcription from RNA polymerase II promoter
GS164320: MP:0003861 abnormal nervous system development
GS166154: MP:0011098 complete embryonic lethality during organogenesis
GS178461: GO:0009987 cellular process
GS210555: GO:0007389 pattern specification process
GS192624: GO:0043231 intracellular membrane-bounded organelle
GS186743: GO:0043227 membrane-bounded organelle
GS198602: GO:0007350 blastoderm segmentation
GS166291: MP:0011108 partial embryonic lethality during organogenesis
GS197707: GO:0016331 morphogenesis of embryonic epithelium
GS167377: MP:0004180 failure of initiation of embryo turning
GS193268: GO:0005575 cellular_component
GS169633: MP:0003456 absent tail
GS194039: GO:1901363 heterocyclic compound binding
GS188190: GO:0006807 nitrogen compound metabolic process
GS164196: MP:0009768 impaired somite development
GS166162: MP:0011090 partial perinatal lethality
GS203749: GO:0001843 neural tube closure
GS209215: GO:0007166 cell surface receptor signaling pathway
GS169379: MP:0004251 failure of heart looping
GS207797: GO:0030154 cell differentiation
GS207581: GO:0007275 multicellular organismal development
GS163051: MP:0000267 abnormal heart development
GS202490: GO:0090130 tissue migration
GS205784: GO:0007351 tripartite regional subdivision
GS191721: GO:0008284 positive regulation of cell proliferation
GS205002: GO:0048856 anatomical structure development
GS163852: MP:0001544 abnormal cardiovascular system physiology
GS86494: Table S1: Hippocampus 17 K microarray data. [DRG]
GS207857: GO:0009058 biosynthetic process
GS192279: GO:0007166 cell surface receptor signaling pathway
GS165466: MP:0003632 abnormal nervous system morphology
GS196863: GO:0030903 notochord development
GS169835: MP:0005389 reproductive system phenotype
GS200490: GO:0061061 muscle structure development
GS203238: GO:0000228 nuclear chromosome
GS164744: MP:0001730 embryonic growth arrest
GS201023: GO:0071704 organic substance metabolic process
GS210610: GO:0048570 notochord morphogenesis
GS190402: GO:0072175 epithelial tube formation
GS194493: GO:0001944 vasculature development
GS191106: GO:0044464 cell part
GS186227: GO:0090304 nucleic acid metabolic process
GS168593: MP:0002088 abnormal embryonic growth/weight/body size
GS204612: GO:0019222 regulation of metabolic process
GS136226: mandible length 18 (Manln18, Published QTL Chr 17)
GS163580: MP:0000538 abnormal urinary bladder morphology
GS181267: GO:0048568 embryonic organ development
GS194555: GO:0031974 membrane-enclosed lumen
GS184449: GO:0044427 chromosomal part
GS177680: GO:0000790 nuclear chromatin
GS170666: MP:0000270 abnormal heart tube morphology
GS182813: GO:0061371 determination of heart left/right asymmetry
GS167833: MP:0001784 abnormal fluid regulation
GS178927: GO:0003705 RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity
GS203607: GO:0034654 nucleobase-containing compound biosynthetic process
GS185033: GO:0048598 embryonic morphogenesis
GS136933: vertebral trabecular bone trait 18 (Vtbt18, Published QTL Chr 17)
GS164864: MP:0004603 absent vertebral arch
GS165488: MP:0001701 incomplete embryo turning
GS169114: MP:0004196 abnormal prenatal growth/weight/body size
GS185585: GO:0044710 single-organism metabolic process
GS187708: GO:0009893 positive regulation of metabolic process
GS204232: GO:0001071 nucleic acid binding transcription factor activity
GS84300: METH responses for body temperature (Published QTL, Chr 17)
GS168502: MP:0002058 neonatal lethality
GS206696: GO:0044702 single organism reproductive process
GS167805: MP:0000150 abnormal rib morphology
GS169630: MP:0001785 edema
GS164126: MP:0001388 abnormal stationary movement
GS124122: monoisoamyl-2,3-dimercaptosuccinate interacting genes (MeSH:C091888) in CTD
GS200373: GO:0060070 canonical Wnt receptor signaling pathway
GS183575: GO:0060070 canonical Wnt receptor signaling pathway